1
|
Sangalli E, Tagliabue E, Sala LL, Prattichizzo F, Uccellatore A, Spada D, Lorino F, de Candia P, Lupini S, Cantone L, Favero C, Madeddu P, Bollati V, Genovese S, Spinetti G. Circulating MicroRNA-15a Associates With Retinal Damage in Patients With Early Stage Type 2 Diabetes. Front Endocrinol (Lausanne) 2020; 11:254. [PMID: 32390950 PMCID: PMC7192007 DOI: 10.3389/fendo.2020.00254] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/07/2020] [Accepted: 04/06/2020] [Indexed: 11/30/2022] Open
Abstract
Circulating microRNAs are potential biomarkers of type 2 diabetes mellitus (T2DM) and related complications. Here, we investigated the association of microRNA-15a with early retinal damage in T2DM. A cohort of untreated subjects screened for intermediate/high risk of T2DM, according to a score assessment questionnaire, and then recognized to have a normal (NGT) or impaired (IGT) glucose tolerance or T2DM was studied. The thickness of the ganglion cell complex (GCC), an early marker of retinal degeneration anteceding overt retinopathy was assessed by Optical Coherence Tomography. Total and extracellular vesicles (EV)-associated microRNA-15a quantity was measured in plasma by real time PCR. MicroRNA-15a level was significantly higher in subjects with IGT and T2DM compared with NGT. MicroRNA-15a abundance was correlated to body mass index and classical diabetes biomarkers, including fasting glucose, HbA1c, insulinemia, and HOMA-IR. Moreover, GCC thickness was significantly reduced in IGT and T2DM subjects compared with NGT controls. Importantly, total microRNA-15a correlated with GCC in IGT subjects, while in T2DM subjects, EV-microRNA-15a negatively correlated with GCC, suggesting that microRNA-15a may monitor initial retinal damage. The assessment of plasma microRNA-15a may help refining risk assessment and secondary prevention in patients with preclinical T2DM.
Collapse
Affiliation(s)
| | | | | | | | - AnnaChiara Uccellatore
- Department of Biomedical and Clinical Science L. Sacco, University of Milan, Milan, Italy
| | | | | | | | - Silvia Lupini
- Department of Biomedical and Clinical Science L. Sacco, University of Milan, Milan, Italy
| | - Laura Cantone
- EPIGET Lab, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - Chiara Favero
- EPIGET Lab, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | - Paolo Madeddu
- Department of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| | - Valentina Bollati
- EPIGET Lab, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
| | | | - Gaia Spinetti
- IRCCS MultiMedica, Milan, Italy
- *Correspondence: Gaia Spinetti
| |
Collapse
|
2
|
La Sala L, Mrakic-Sposta S, Tagliabue E, Prattichizzo F, Micheloni S, Sangalli E, Specchia C, Uccellatore AC, Lupini S, Spinetti G, de Candia P, Ceriello A. Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D. Cardiovasc Diabetol 2019; 18:18. [PMID: 30803440 PMCID: PMC6388471 DOI: 10.1186/s12933-019-0824-2] [Citation(s) in RCA: 46] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/02/2019] [Accepted: 02/08/2019] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND Impaired glucose tolerance (IGT) is a risk factor for the development of diabetes and related complications that ensue. Early identification of at-risk individuals might be beneficial to reduce or delay the progression of diabetes and its related complications. Recently, microRNAs emerged as potential biomarkers of diseases. The aim of the present study was to evaluate microRNA-21 as a potential biomarker for the risk of developing diabetes in adults with IGT and to investigate its downstream effects as the generation of reactive oxygen species (ROS), the induction of manganese-superoxide dismutase-2 (SOD2), and the circulating levels of 4-HNE (4-hydroxynonenal). METHODS To evaluate the prognostic and predictive values of plasmatic microRNA-21 in identifying metabolic derangements, we tested a selected cohort (n = 115) of subjects enrolled in the DIAPASON Study, whom were selected on ADA criteria for 2hPG. Statistical analysis was performed using ANOVA or the Kruskal-Wallis test as appropriate. ROC curves were drawn for diagnostic accuracy of the tests; positive and negative predictive values were performed, and Youden's index was used to seek the cut-off optimum truncation point. ROS, SOD2 and 4-HNE were also evaluated. RESULTS We observed significant upregulation of microRNA-21 in IGT and in T2D subjects, and microRNA-21 was positively correlated with glycaemic parameters. Diagnostic performance of microRNA-21 was high and accurate. We detected significant overproduction of ROS by electron paramagnetic resonance (EPR), significant accumulation of the lipid peroxidation marker 4-HNE, and defective SOD2 antioxidant response in IGT and newly diagnosed, drug-naïve T2D subjects. In addition, ROC curves demonstrated the diagnostic accuracy of markers used. CONCLUSIONS our data demonstrate that microRNA-21 is associated with prediabetic status and exhibits predictive value for early detection of glucose imbalances. These data could provide novel clues for miR-based biomarkers to evaluate diabetes.
Collapse
Affiliation(s)
- Lucia La Sala
- Department of Cardiovascular and Dysmetabolic Diseases, IRCCS MultiMedica, Via Fantoli 16/15, 20138, Milan, Italy.
| | - Simona Mrakic-Sposta
- Institute of Molecular Bioimaging and Physiology, National Research Council, Segrate, Italy
| | | | - Francesco Prattichizzo
- Department of Cardiovascular and Dysmetabolic Diseases, IRCCS MultiMedica, Via Fantoli 16/15, 20138, Milan, Italy
| | - Stefano Micheloni
- Department of Cardiovascular and Dysmetabolic Diseases, IRCCS MultiMedica, Via Fantoli 16/15, 20138, Milan, Italy
| | - Elena Sangalli
- Department of Cardiovascular and Dysmetabolic Diseases, IRCCS MultiMedica, Via Fantoli 16/15, 20138, Milan, Italy
| | - Claudia Specchia
- Department of Translational Biomedicine, University of Brescia, Brescia, Italy
| | | | | | - Gaia Spinetti
- Department of Cardiovascular and Dysmetabolic Diseases, IRCCS MultiMedica, Via Fantoli 16/15, 20138, Milan, Italy
| | - Paola de Candia
- Department of Cardiovascular and Dysmetabolic Diseases, IRCCS MultiMedica, Via Fantoli 16/15, 20138, Milan, Italy
| | - Antonio Ceriello
- Department of Cardiovascular and Dysmetabolic Diseases, IRCCS MultiMedica, Via Fantoli 16/15, 20138, Milan, Italy.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain
| |
Collapse
|
3
|
de Candia P, Spinetti G, Specchia C, Sangalli E, La Sala L, Uccellatore A, Lupini S, Genovese S, Matarese G, Ceriello A. A unique plasma microRNA profile defines type 2 diabetes progression. PLoS One 2017; 12:e0188980. [PMID: 29200427 PMCID: PMC5714331 DOI: 10.1371/journal.pone.0188980] [Citation(s) in RCA: 76] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Accepted: 11/16/2017] [Indexed: 01/21/2023] Open
Abstract
A major unmet medical need to better manage Type 2 Diabetes (T2D) is the accurate disease prediction in subjects who show glucose dysmetabolism, but are not yet diagnosed as diabetic. We investigated the possibility to predict/monitor the progression to T2D in these subjects by retrospectively quantifying blood circulating microRNAs in plasma of subjects with i) normal glucose tolerance (NGT, n = 9); ii) impaired glucose tolerance (IGT, n = 9), divided into non-progressors (NP, n = 5) and progressors (P, n = 4) based on subsequent diabetes occurrence, and iii) newly diagnosed T2D (n = 9). We found that impaired glucose tolerance associated with a global increase of plasma circulating microRNAs. While miR-148 and miR-222 were specifically modulated in diabetic subjects and correlated with parameters of glucose tolerance, the most accentuated microRNA dysregulation was found in NP IGT subjects, with increased level of miR-122, miR-99 and decreased level of let-7d, miR-18a, miR-18b, miR-23a, miR-27a, miR-28 and miR-30d in comparison with either NGT or T2D. Interestingly, several of these microRNAs significantly correlated with parameters of cholesterol metabolism. In conclusion, we observed the major perturbation of plasma circulating microRNA in NP pre-diabetic subjects and identified a unique microRNA profile that may become helpful in predicting diabetic development.
Collapse
Affiliation(s)
- Paola de Candia
- Department of Diabetology and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy
- * E-mail:
| | - Gaia Spinetti
- Department of Diabetology and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy
| | - Claudia Specchia
- Department of Diabetology and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy
- Department of Molecular and Translational Medicine, University of Brescia, Brescia Italy
| | - Elena Sangalli
- Department of Diabetology and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy
| | - Lucia La Sala
- Department of Diabetology and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy
| | | | - Silvia Lupini
- Department of Diabetology and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy
| | - Stefano Genovese
- Department of Diabetology and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy
| | - Giuseppe Matarese
- Laboratory of Immunology, Institute of Endocrinology and Experimental Oncology, National Research Council (IEOS-CNR), Naples, Italy
- Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, Naples, Italy
| | - Antonio Ceriello
- Department of Diabetology and Dysmetabolic Diseases, IRCCS MultiMedica, Milan, Italy
- Insititut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), C/Rosselló, Barcelona, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain
| |
Collapse
|
4
|
Vecchione C, Villa F, Carrizzo A, Spinelli CC, Damato A, Ambrosio M, Ferrario A, Madonna M, Uccellatore A, Lupini S, Maciag A, Ryskalin L, Milanesi L, Frati G, Sciarretta S, Bellazzi R, Genovese S, Ceriello A, Auricchio A, Malovini A, Puca AA. A rare genetic variant of BPIFB4 predisposes to high blood pressure via impairment of nitric oxide signaling. Sci Rep 2017; 7:9706. [PMID: 28852218 PMCID: PMC5574984 DOI: 10.1038/s41598-017-10341-x] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2017] [Accepted: 08/08/2017] [Indexed: 01/04/2023] Open
Abstract
BPIFB4 is associated with exceptional longevity: four single-nucleotide polymorphisms distinguish the wild-type form from a longevity-associated variant conferring positive effects on blood pressure. The effect of a rare variant (RV; allele frequency, 4%) on blood pressure is unknown. Here, we show that overexpression of RV-BPIFB4 in ex-vivo mouse vessels impairs phosphorylation of endothelial nitric oxide synthase (eNOS), blunting acetylcholine-evoked vasorelaxation; in vivo, virally mediated overexpression of RV-BPIFB4 increases blood pressure, an action absent in eNOS-deficient mice. In humans, we found RV carriers to have increased diastolic blood pressure, a finding that was more marked in subjects on anti-hypertensive medication; moreover, recombinant RV-BPIFB4 protein impaired eNOS function in ex-vivo human vessels. Thus, RV-BPIFB4 acts directly on blood pressure homeostasis and may represent a novel biomarker of vascular dysfunction and hypertension.
Collapse
Affiliation(s)
- Carmine Vecchione
- IRCCS Neuromed, 86077, Pozzilli (IS), Italy. .,Department of Medicine and Surgery, University of Salerno, Fisciano, 84084, (SA), Italy.
| | - Francesco Villa
- Cardiovascular Research Unit, IRCCS MultiMedica, 20099, Sesto San Giovanni (MI), Italy
| | | | | | | | | | - Anna Ferrario
- Institute of Biomedical Technologies, National Research Council, 20090, Segrate (MI), Italy
| | | | | | - Silvia Lupini
- University of Milan, Via Festa del Perdono, 20122, Milan, Italy
| | - Anna Maciag
- Cardiovascular Research Unit, IRCCS MultiMedica, 20099, Sesto San Giovanni (MI), Italy
| | - Larisa Ryskalin
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, 56126, Italy
| | - Luciano Milanesi
- Institute of Biomedical Technologies, National Research Council, 20090, Segrate (MI), Italy
| | - Giacomo Frati
- IRCCS Neuromed, 86077, Pozzilli (IS), Italy.,Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100, Latina, Italy
| | - Sebastiano Sciarretta
- IRCCS Neuromed, 86077, Pozzilli (IS), Italy.,Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, 04100, Latina, Italy
| | - Riccardo Bellazzi
- Laboratory of Informatics and Systems Engineering for Clinical Research, Istituti Clinici Scientifici Maugeri, 27100, Pavia, Italy.,Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy
| | - Stefano Genovese
- Diabetes Endocrine and Metabolic Diseases Unit, IRCCS MultiMedica, 20099, Sesto San, Giovanni (MI), Italy
| | - Antonio Ceriello
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.,Department of Cardiovascular and Metabolic Diseases, IRCCS MultiMedica, 20099, Sesto San, Giovanni (MI), Italy
| | - Alberto Auricchio
- TIGEM (Telethon Institute of Genetics and Medicine), 80078, Pozzuoli, Italy.,Department of Translational Medicine, "Federico II" University, Napoli, Italy
| | - Alberto Malovini
- Laboratory of Informatics and Systems Engineering for Clinical Research, Istituti Clinici Scientifici Maugeri, 27100, Pavia, Italy
| | - Annibale Alessandro Puca
- Department of Medicine and Surgery, University of Salerno, Fisciano, 84084, (SA), Italy. .,Cardiovascular Research Unit, IRCCS MultiMedica, 20099, Sesto San Giovanni (MI), Italy.
| |
Collapse
|
5
|
Ravera G, Castaldo C, Cesario R, Lupini S, Podda S, Righetti G. High power RF components for the IBW experiment on FTU. Fusion Engineering and Design 2007. [DOI: 10.1016/j.fusengdes.2007.05.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
6
|
Coletti A, Bartolini L, Ferri De Collibus M, Fornetti G, Lo Bue A, Lupini S, Neri C, Pollastrone F, Semeraro L, Talarico C. AM laser system (IVVS) for the ITER in vessel viewing and ranging. Fusion Engineering and Design 2003. [DOI: 10.1016/s0920-3796(03)00312-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
7
|
Bertocchi A, Buceti G, Centioli C, Granucci G, Iannone F, Lupini S, Mazza G, Panella M, Vitale V. New digital waveform reference for ECRH on FTU. Fusion Engineering and Design 2002. [DOI: 10.1016/s0920-3796(02)00037-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
8
|
Talarico C, Baldarelli M, Coletti A, Lupini S, Neri C, Riva M, Semeraro L. Laser in vessel viewing system for activated areas: mechanical design, manufacturing and tests. Fusion Engineering and Design 2000. [DOI: 10.1016/s0920-3796(00)00415-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
9
|
Nini G, Calvieri S, Gatti S, Lupini S, Bianchi L, Di Carlo A, Carrozzo AM, Iraci S, Marinaro C. [Complete pachydermoperiostosis. Ultrastructural and peripheral vascular system studies]. GIORN ITAL DERMAT V 1988; 123:481-7. [PMID: 3248819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
10
|
Nini G, Bianchi L, Gatti S, Iraci S, Carrozzo AM, Marinaro C, Lupini S, Secondari C, Abbatiello A. [Acute gangrene of the face in a diabetic]. GIORN ITAL DERMAT V 1988; 123:359-61. [PMID: 3225001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|